Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multikarya Asia Pasifik Raya Tbk. (MKAP) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multikarya Asia Pasifik Raya Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multikarya Asia Pasifik Raya Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Multikarya Asia Pasifik Raya Tbk. trades at Rp1,160 (market cap 3.79T, 136.3K 24h volume). The key difference: Multikarya Asia Pasifik Raya Tbk. is far larger — about 6.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 136.3K). Which is the better fit depends on your goals.

LABSMKAP
Market Cap
576.7B3.79T
Volume
3.48M136.3K
Lot
34.82K1.36K
Turnover
522.79M158.11M
Average Price
150.131,160.03
Value
522.79M158.11M
Indicative Equilibrium Price
1481,160
Indicative Equilibrium Volume
3501.22K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MKAP
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multikarya Asia Pasifik Raya Tbk.

PT Multikarya Asia Pasifik Raya Tbk (the Company) was established on May 16, 2002 in Jakarta, Indonesia under the name of PT Mudking Asia Pasifik Raya, herein after, based on Notarial Deed No. 43 of Yunardi, S.H. The Company started its commercial operations in 2002.

Read more on MKAP